Results 31 to 40 of about 3,556,677 (271)

659 Blocking cytokine IL-1 with anakinra for the prevention of cytokine release syndrome in COVID-19

open access: yesJournal for ImmunoTherapy of Cancer, 2020
Background: The novel coronavirus, known as SARS-CoV-2, or COVID-19 became a pandemic in early 2020, causing significant human suffering and economic woes globally.
Jason Williams   +2 more
doaj   +2 more sources

Extracorporeal cytokine removal in chimeric antigen receptor T-cell therapy associated cytokine release syndrome in patient with acute lymphoblastic leukemia. Case report

open access: yesТерапевтический архив, 2021
Сytokine release syndrome is the common complication of CAR-T therapy. We report a case of patient with B-cell acute lymphoblastic leukemia developing сytokine release syndrome with shock and multiple organ failure and requiring cytokine removal and ...
Antonina E. Shchekina   +9 more
doaj   +1 more source

Covid-19 Cytokine Release Syndrome and Drugs [PDF]

open access: yes, 2020
A survey of literature about the Cytokine Release Syndrome in Covid-19 and of some drugs used or proposed against ...
Sparavigna, Amelia Carolina   +1 more
core   +1 more source

Collapsing Focal Segmental Glomerulosclerosis and Acute Kidney Injury Associated With Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: A Case Report

open access: yesKidney Medicine, 2021
Chimeric antigen receptor T (CAR-T) cell treatment is a rapidly emerging therapy for relapsed/refractory hematologic malignancies. Although cytokine release syndrome is a common complication, a concomitant development of biopsy-proven collapsing ...
Ratna Acharya   +3 more
doaj   +1 more source

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy

open access: yesDiseases, 2022
Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy is an innovative therapeutic option for addressing certain recurrent or refractory hematological malignancies.
Puri Ferreros, Isabel Trapero
doaj   +1 more source

Cytokine release syndrome in severe COVID-19 [PDF]

open access: yesScience, 2020
Lessons from arthritis and cell therapy in cancer patients point to therapy for severe ...
Moore, John B., June, Carl H.
openaire   +2 more sources

Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions [PDF]

open access: yes, 2016
In October 2013, the International Life Sciences Institute - Health and Environmental Sciences Institute Immunotoxicology Technical Committee (ILSI-HESI ITC) held a one-day workshop entitled, “Workshop on Cytokine Release: State-of-the-Science, Current ...
Finco, D   +14 more
core   +1 more source

STAT: Cytokine Release Syndrome

open access: yesClinical Journal of Oncology Nursing, 2020
Cytokine release syndrome is a systemic inflammatory condition that may occur after treatment with some types of immunotherapy.
openaire   +3 more sources

COVID-19 cytokine storm: The anger of inflammation

open access: yes, 2020
Patients with COVID-19 who require ICU admission might have the cytokine storm. It is a state of out-of-control release of a variety of inflammatory cytokines. The molecular mechanism of the cytokine storm has not been explored extensively yet.
Keshavarz, Mohsen   +4 more
core   +1 more source

Sarilumab (IL-6R antagonist) in critically ill patients with cytokine release syndrome by SARS-CoV2 [PDF]

open access: yes, 2021
Blocking IL-6 pathways with sarilumab, a fully human anti-IL-6R antagonist may potentially curb the inflammatory storm of SARS-CoV2. In the present emergency scenario, we used "off-label" sarilumab in 5 elderly patients in life-threatening condition not ...
Jordi Casademont   +26 more
core   +1 more source

Home - About - Disclaimer - Privacy